BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31710844)

  • 1. "Endothelial Dysfunction in Resuscitated Cardiac Arrest (ENDO-RCA): Safety and efficacy of low-dose Iloprost, a prostacyclin analogue, in addition to standard therapy, as compared to standard therapy alone, in post-cardiac-arrest-syndrome patients.".
    Meyer ASP; Johansson PI; Kjaergaard J; Frydland M; Meyer MAS; Henriksen HH; Thomsen JH; Wiberg SC; Hassager C; Ostrowski SR
    Am Heart J; 2020 Jan; 219():9-20. PubMed ID: 31710844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial Dysfunction in Resuscitated Cardiac Arrest (ENDO-RCA): safety and efficacy of low-dose prostacyclin administration and blood pressure target in addition to standard therapy, as compared to standard therapy alone, in post-cardiac arrest syndrome patients: study protocol for a randomized controlled trial.
    Meyer AS; Ostrowski SR; Kjaergaard J; Johansson PI; Hassager C
    Trials; 2016 Aug; 17():378. PubMed ID: 27484224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathoadrenal activation and endothelial damage are inter correlated and predict increased mortality in patients resuscitated after out-of-hospital cardiac arrest. a post Hoc sub-study of patients from the TTM-trial.
    Johansson PI; Bro-Jeppesen J; Kjaergaard J; Wanscher M; Hassager C; Ostrowski SR
    PLoS One; 2015; 10(3):e0120914. PubMed ID: 25789868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose Iloprost effect on platelet aggregation in comatose out-of-hospital cardiac arrest patients: A predefined sub-study of the ENDO-RCA randomized -phase 2- trial.
    Meyer ASP; Ostrowski SR; Kjærgaard J; Frydland M; Thomsen JH; Johansson PI; Hassager C
    J Crit Care; 2020 Apr; 56():197-202. PubMed ID: 31945586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Level of systemic inflammation and endothelial injury is associated with cardiovascular dysfunction and vasopressor support in post-cardiac arrest patients.
    Bro-Jeppesen J; Johansson PI; Kjaergaard J; Wanscher M; Ostrowski SR; Bjerre M; Hassager C
    Resuscitation; 2017 Dec; 121():179-186. PubMed ID: 28947390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial activation/injury and associations with severity of post-cardiac arrest syndrome and mortality after out-of-hospital cardiac arrest.
    Bro-Jeppesen J; Johansson PI; Hassager C; Wanscher M; Ostrowski SR; Bjerre M; Kjaergaard J
    Resuscitation; 2016 Oct; 107():71-9. PubMed ID: 27523954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intraoperative and 6-h postoperative intravenous administration of low-dose prostacyclin on the endothelium, hemostasis, and hemodynamics in patients undergoing a pancreaticoduodenoctemy: a randomized-controlled pilot study.
    Johansson PI; Mortensen CR; Nielsen T; Tollund C; Stensballe J; Hansen CP; Frederiksen HJ; Ostrowski SR
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):400-406. PubMed ID: 27926661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traumatic Endotheliopathy: A Prospective Observational Study of 424 Severely Injured Patients.
    Johansson PI; Henriksen HH; Stensballe J; Gybel-Brask M; Cardenas JC; Baer LA; Cotton BA; Holcomb JB; Wade CE; Ostrowski SR
    Ann Surg; 2017 Mar; 265(3):597-603. PubMed ID: 27144442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in circulating endothelial cell adhesion molecule and thrombomodulin levels during oral iloprost treatment in rheumatoid arthritis patients: preliminary results.
    Boehme MW; Gao IK; Norden C; Lemmel EM
    Rheumatol Int; 2006 Feb; 26(4):340-7. PubMed ID: 15700117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of iloprost in patients with septic shock-induced endotheliopathy-Protocol for the multicenter randomized, placebo-controlled, blinded, investigator-initiated trial.
    Bestle MH; Clausen NE; Søe-Jensen P; Kristiansen KT; Lange T; Johansson PI; Stensballe J; Perner A
    Acta Anaesthesiol Scand; 2020 May; 64(5):705-711. PubMed ID: 31950481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulopathy in patients with acute pulmonary embolism: a pilot study of whole blood coagulation and markers of endothelial damage.
    Lehnert P; Johansson PI; Ostrowski SR; Møller CH; Bang LE; Olsen PS; Carlsen J
    Scand J Clin Lab Invest; 2017 Feb; 77(1):19-26. PubMed ID: 27724023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-administration of iloprost and eptifibatide in septic shock (CO-ILEPSS)-a randomised, controlled, double-blind investigator-initiated trial investigating safety and efficacy.
    Berthelsen RE; Ostrowski SR; Bestle MH; Johansson PI
    Crit Care; 2019 Sep; 23(1):301. PubMed ID: 31488213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy.
    Kramm T; Eberle B; Guth S; Mayer E
    Eur J Cardiothorac Surg; 2005 Dec; 28(6):882-8. PubMed ID: 16242948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
    Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it possible to improve outcome in patients undergoing surgery for acute limb ischemia? Can iloprost, a prostacyclin analogue, be helpful?
    de Donato G; Gussoni G; de Donato G
    Chir Ital; 2004; 56(6):769-80. PubMed ID: 15771029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): a double-blind, randomised, placebo-controlled trial. The European TAO Study Group.
    Eur J Vasc Endovasc Surg; 1998 Apr; 15(4):300-7. PubMed ID: 9610341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of prostacyclin infusion on markers of endothelial activation and damage in mechanically ventilated patients with SARS-CoV-2 infection.
    Vigstedt M; Søe-Jensen P; Bestle MH; Clausen NE; Kristiansen KT; Lange T; Stensballe J; Perner A; Johansson PI
    J Crit Care; 2022 Jun; 69():154010. PubMed ID: 35183892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of iloprost inhalation on postoperative outcome in high-risk cardiac surgical patients: a prospective randomized-controlled multicentre trial (ILOCARD).
    Winterhalter M; Rex S; Stoppe C; Kienbaum P; Müller HH; Kaufmann I; Kuppe H; Dongas A; Zwissler B;
    Can J Anaesth; 2019 Aug; 66(8):907-920. PubMed ID: 30756339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost.
    Palatianos GM; Foroulis CN; Vassili MI; Matsouka P; Astras GM; Kantidakis GH; Iliopoulou E; Melissari EN
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):548-54. PubMed ID: 14762367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac Arrest: A Randomized Controlled Trial.
    Wiberg S; Hassager C; Schmidt H; Thomsen JH; Frydland M; Lindholm MG; Høfsten DE; Engstrøm T; Køber L; Møller JE; Kjaergaard J
    Circulation; 2016 Dec; 134(25):2115-2124. PubMed ID: 27838646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.